Gary A. Rhodes
Elanco (United States)(US)
Publications by Year
Research Areas
Neuroscience and Neuropharmacology Research, Peroxisome Proliferator-Activated Receptors, Metabolism, Diabetes, and Cancer, Adipose Tissue and Metabolism, Pharmacological Receptor Mechanisms and Effects
Most-Cited Works
- → Design, Synthesis, and Pharmacological Characterization of (+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY354740): A Potent, Selective, and Orally Active Group 2 Metabotropic Glutamate Receptor Agonist Possessing Anticonvulsant and Anxiolytic Properties(1997)392 cited
- → A Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist with a Unique in Vitro Profile and Potent Glucose and Lipid Effects in Rodent Models of Type 2 Diabetes and Dyslipidemia(2005)64 cited
- → 2-Alkoxydihydrocinnamates as PPAR agonists. Activity modulation by the incorporation of phenoxy substituents(2004)29 cited
- → Process Development of (1S,2S,5R,6S)- Spiro[bicyclo[3.1.0]hexane-2‘,5‘-dioxo-2,4‘-imidazolidine]-6-carboxylic Acid, (R)-α-Methylbenzenemethanamine Salt (LSN344309)(2005)11 cited
- → Practical Asymmetric Synthesis of an Edivoxetine·HCl Intermediate via an Efficient Diazotization Process(2015)7 cited
- → Synthesis and evaluation of aminomethyl dihydrocinnamates as a new class of PPAR ligands(2006)3 cited
- → ChemInform Abstract: Design, Synthesis, and Pharmacological Characterization of (+)‐2‐ Aminobicyclo(3.1.0)hexane‐2,6‐dicarboxylic Acid (LY354740): A Potent, Selective, and Orally Active Group 2 Metabotropic Glutamate Receptor Agonist Possessing Anticonvulsant and Anxiolytic Properties.(1997)